Date of filling in this questionnaire or last update: 12/01/2022
1. IDENTIFICATION & BASIC DESCRIPTION
Cohort name
  Fibronit - Broni
Country
 

  • Italy

Please provide any other information on the cohort location/s if needed
  Province of Pavia, Lombardy Region
Name
  Enrico Oddone
Institution
  University of Pavia
Email
  enrico.oddone@unipv.it
Name
  Daniela Ferrante
Institution
  University of Easter Piedmont
Email
  daniela.ferrante@med.uniupo.it
Upload files
 

Contact Principal Investigator (name)
  Enrico Oddone
Is this cohort part of a consortium? (name consortium)
  Italian Pool of Asbestos Workers Cohorts
Upload files
 

Participation in pooled analyses
 

  • The cohort is potentially interested in participating in pooled analyses of (European) occupational cohort studies (note pooled analyses also includes remote decentralized analyses that would not require any transfer of primary data as well as meta-analyses).

Main aim of cohort, please briefly describe the main objectives of the cohort
  To describe mortality among a cohort of former asbestos-cement workers
Study design (please select as many as appropriate)
 

  • Retrospective cohort

Comparators (please select as many as appropriate)
 

  • Internal study population
  • External study population (includes SMR/SIR studies)

Enrollment
  Completed
Age range at entry (main cohort)
 

Minimum Maximum Mean
21 63

Men at last follow-up
  1663
Women at last follow-up
  155
Children (<18 years) at last follow-up
  -
2. OUTCOME FOLLOW-UP
Type of data for outcome follow-up (please select as many as appropriate)
 

  • Death certificate

First follow-up period (provide year)
  1950-2004
Last follow-up period (provide year)
  1950-2014
Number of follow-ups after baseline (provide number)
  1
3. OCCUPATIONAL EXPOSURES
Source of exposure data collected (please select as many as appropriate)
 

  • Job-employment records

Occupational history/time frame
  Current, at enrollment
Occupational coding performed
  No
Main categories
 

  • Dusts and fibres

Dusts and fibres | Fibres
 

  • Asbestos (any form of asbestos chrysotile, crocidolite, tremolite, anthophyllite, etc. or asbestos-containing material)

4. OUTCOMES EVALUATED
Baseline - type of outcome data collected (select more than one if applicable)
 

  • Death certificates

Follow-up - type of outcome data collected (select more than one if applicable)
 

  • Death certificates

Outcome type (please select as many as appropriate)
 

  • Mortality

Diagnostic groups based on ICD10
 

  • C + D Neoplasms
  • G Disease in the nervous system
  • I Heart disease
  • I Cerebrovascular diseases
  • J Respiratory disease
  • K Diseases of peritoneum, liver

C + D Neoplasms
 

  • Leukemia
  • Malignant neoplasms gastro intes. system including liver, gall bladder, pancreas
  • Malignant neoplasm lung
  • Mesothelioma
  • Other malignant neoplasm of respiratory and intrathoracic organs, heart, pleura
  • Malignant neoplasm of bone and articular cartilage
  • Melanoma and other malignant neoplasms of skin
  • Neoplasms connective and soft tissue including nerves
  • Malignant neoplasm of breast
  • Malignant neoplasms, females gynecological
  • Malignant neoplasms of male genital organs
  • Malignant neoplasm of urinary tract and kidney
  • Malignant neoplasms of eye, brain and other parts of central nervous system
  • Malignant neoplasms of thyroid and other endocrine glands
  • Malignant neoplasms of ill-defined, secondary and unspecified sites
  • Malignant neoplasm without specification of site including excl. leukemia

I Heart disease
 

  • Acute myocardial infarction
  • Chronic ischaemic heart disease
  • Heart failure

I Cerebrovascular diseases
 

  • Stroke, not specified as haemorrhage or infarction

J Respiratory disease
 

  • Chronic Bronchitis
  • Emphysema
  • Chronic obstructive pulmonary disease (COPD)
  • Pneumoconiosis

K Diseases of peritoneum, liver
 

  • Fibrosis and cirrhosis of liver

6. Other Information
Possibility for linkage to data registries/data enrichment via data linkage
 

  • Cancer incidence
  • Mortality register